Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study

Gregory Cheng, Mansoor N. Saleh, Claus Werenberg Marcher, +6

The Lancet

ThrombopoiesisThrombosisVenous ThrombosisAutoimmune DiseaseBlood Platelet +10

Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients

Ulrich Germing, Norbert Gattermann, Corinna Strupp, +2

Leukemia Research

Hematological MalignancyBone Marrow FailurePrimary Myelodysplastic SyndromesMixed-phenotype Acute LeukemiaMalignant Blood Disorder +7

Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid

Andrea Kuendgen, Corinna Strupp, Manuel Aivado, +5

Blood

Dual inhibition of MDMX and MDM2 as a therapeutic strategy in leukemia

Luis A. Carvajal, Daniela Ben Neriah, Adrien Senecal, +19

Science Translational Medicine

Chemoprevention StrategyMixed-phenotype Acute LeukemiaTherapeutic StrategyCancer BiologyTumor Biology +21

Clinical, morphological, cytogenetic, and prognostic features of patients with myelodysplastic syndromes and del(5q) including band q31

Aristoteles Giagounidis, Ulrich Germing, Sabine Haase, +8

Leukemia

Hematological MalignancyHealth SciencesMixed-phenotype Acute LeukemiaAplastic AnemiaHematology +6

Essential role of Jun family transcription factors in PU.1 knockdown–induced leukemic stem cells

Ulrich Steidl, Frank Rosenbauer, Roel G.W. Verhaak, +15

Nature Genetics

Transcriptional RegulationEssential RoleCell RegulationMedicineImmunology +8

Pharmacologic Activation of p53 Triggers Viral Mimicry Response Thereby Abolishing Tumor Immune Evasion and Promoting Antitumor Immunity

Xiaolei Zhou, Madhurendra Singh, Gema Sanz, +9

Cancer Discovery

Thalidomide for the treatment of patients with myelodysplastic syndromes

Corinna Strupp, Ulrich Germing, Manuel Aivado, +3

Leukemia

Hematological MalignancyThrombosisBone Marrow FailureHematologyPharmacotherapy +3

Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow–derived and circulating human CD34+ hematopoietic stem cells

Ulrich Steidl, Ralf Kronenwett, Ulrich‐Peter Rohr, +10

Blood

Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFα antibody

Guido Kobbe, Philipp Schneider, Ulrich‐Peter Rohr, +7

Bone Marrow Transplantation

InflammationTransplantationAutoimmune DiseaseImmunosuppressive TherapyImmunology +8